ARC
ONCY

Advisor Resource Council’s Oncolytics Biotech ONCY Stock Holding History

Advisor Resource Council’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-100,000
Closed -$135K – 425
2023
Q4 		$135K Buy
+100,000
New +$156K 0.02% 472
2022
Q3 		– Sell
-100,000
Closed -$101K – 385
2022
Q2 		$101K Buy
+100,000
New +$122K 0.01% 507
2022
Q1 		– Sell
-100,000
Closed -$139K – 429
2021
Q4 		$139K Buy
+100,000
New +$185K 0.01% 561
2021
Q3 		– Sell
-101,000
Closed -$280K – 395
2021
Q2 		$280K Buy
+101,000
New +$309K 0.03% 405

Other funds holding ONCY

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Advisor Resource Council's ONCY Position: Q1 2024 in Review

Advisor Resource Council sold out of Oncolytics Biotech (ONCY) in Q1 2024, closing a stake of 100,000 shares — an estimated $135K sold.

Advisor Resource Council first reported a position in ONCY in Q2 2021 and held it in 4 quarters. The position peaked at $280K in Q2 2021. 36 funds tracked by Wall St. Rank hold ONCY as of Q1 2024.

  • Advisor Resource Council reported no remaining Oncolytics Biotech position as of Q1 2024 after selling out during the quarter.
  • Advisor Resource Council sold 100,000 Oncolytics Biotech shares in Q1 2024, an estimated $135K.
  • Advisor Resource Council first reported a position in Oncolytics Biotech in Q2 2021 and held it in 4 quarters.
  • Advisor Resource Council's Oncolytics Biotech position peaked at $280K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2024.

Based on Advisor Resource Council's 13F filing for Q1 2024, filed 19 Apr 2024.